SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AMAG Pharmaceuticals, Inc. Release: Rienso® (Ferumoxytol) Receives European Marketing Authorization for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
Your Message